rosiglitazone has been researched along with tocotrienol, delta in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mo, H; Shen, CL; Torabi, S; Yeganehjoo, H | 1 |
1 other study(ies) available for rosiglitazone and tocotrienol, delta
Article | Year |
---|---|
Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Animals; Cell Differentiation; Down-Regulation; Glucose; Glucose Transporter Type 4; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lovastatin; Mevalonic Acid; Mice; PPAR gamma; Protein Serine-Threonine Kinases; Rosiglitazone; Thiazolidinediones; Triglycerides; Vitamin E | 2016 |